GCISN 1985.
Methods | multicentre, double blind, randomized, placebo controlled, parallel groups | |
Participants | Senile cerebral insufficiency mild to moderate; 82 patients received nicergoline, 80 placebo; age > 55 yr. | |
Interventions | Nicergoline or Placebo 20mg. twice a day (os) for 6 months | |
Outcomes | SCAG for efficacy; adverse events for safety | |
Notes | It describes also a crossover study but with no data available for inclusion in this review |